ArticlePloS one2013

Exploiting MEK inhibitor-mediated activation of ERα for therapeutic intervention in ER-positive ovarian carcinoma.

June Y Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.